Clinical Trial Update: A Study of E7386 in Participants With Advanced Solid Tumor Including Colorectal Cancer (CRC) [Phase 1]

View source ↗

Summary

Phase 1 study update for Eisai's E7386 in participants with advanced solid tumors, including colorectal cancer, currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Gastrointestinal Cancer

Drugs mentioned

• E7386

Snippet

Sponsor: Eisai Co., Ltd. | Conditions: Solid Neoplasms, Colorectal Neoplasms | Phase 1 | Status: ACTIVE_NOT_RECRUITING